Clinical Study
Sentinel Lymph Node Biopsy in Breast Cancer Patients by Means of Indocyanine Green Using the Karl Storz VITOM® Fluorescence Camera
| | | % |
| Patients | 99 | 100,0 |
| Nodes detected per patient (mean, range) | 2.2 | 1–7 | Zero | 0 | 0,0 | One | 39 | 39,4 | Two | 29 | 29,3 | Three | 18 | 18,2 | More than three | 13 | 13,3 |
| Nodes detected | 220 | 100.0 | Both tracers | 167 | 75,9 | By Tc | 172 | 78,2 | By Tc only | 5 | 2,3 | By ICG | 215 | 97,7 | By ICG only | 48 | 21,8 |
| Patients with tumor-affected SLN | 21 | | Tumor-affected SLN detected per patient (mean, range) | 1.3 | 1–3 | Tumor-affected SLN | 28 | 100.0 | Tumor-affected SLN detected by both tracers | 23 | 82.1 | Tumor-affected SLN detected by Tc | 24 | 85.7 | Tumor-affected SLN detected by Tc only | 1 | 3.6 | Tumor-affected SLN detected by ICG | 27 | 96.4 | Tumor-affected SLN detected by ICG only | 4 | 14.3 |
|
|